Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Condensed Consolidated Statements of Operations        
Revenue     $ 1,101  
Operating expenses:        
Research and development $ 10,041 $ 9,525 19,669 $ 17,790
General and administrative 3,472 2,540 6,558 4,911
Total operating expenses 13,513 12,065 26,227 22,701
Loss from operations (13,513) (12,065) (25,126) (22,701)
Other income, net 145 44 243 92
Net loss (13,368) (12,021) (24,883) (22,609)
Accrued dividends on preferred stock   (1,823)   (3,560)
Net loss applicable to common stockholders $ (13,368) $ (13,844) $ (24,883) $ (26,169)
Net loss per share applicable to common stockholders - basic and diluted $ (0.52) $ (5.42) $ (1.02) $ (10.57)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 25,584,147 2,553,146 24,511,205 2,475,576